Your browser doesn't support javascript.
Tyrosine kinase inhibitors and COVID-19.
Semih, Basci; Tugçe Nur, Yigenoglu; Mehmet Sinan, Dal; Serdal, Korkmaz; Burhan, Turgut; Fevzi, Altuntas.
  • Semih B; Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Tugçe Nur Y; Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Mehmet Sinan D; Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Serdal K; Department of Hematology, Kayseri City Hospital, University of Health Sciences, Kayseri, Turkey.
  • Burhan T; Department of Hematology, School of Medicine, Namik Kemal University, Tekirdag, Turkey.
  • Fevzi A; Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
J Oncol Pharm Pract ; 26(8): 2072-2073, 2020 12.
Article in English | MEDLINE | ID: covidwho-883519
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / COVID-19 Limits: Humans Language: English Journal: J Oncol Pharm Pract Journal subject: Pharmacy Year: 2020 Document Type: Article Affiliation country: 1078155220967081

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / COVID-19 Limits: Humans Language: English Journal: J Oncol Pharm Pract Journal subject: Pharmacy Year: 2020 Document Type: Article Affiliation country: 1078155220967081